John M. Kirkwood, MD

Professor of Medicine, Dermatology and Co-Director, Melanoma and Skin Cancer P
UPMC Hillman Cancer Center, United States

Presentation(s):

• 63: Adjuvant therapy with nivolumab versus placebo in patients with resected stage IIB/C melanoma (CheckMate 76K)

  Friday, March 24, 2023
  11:24 AM – 11:34 AM

  Disclosure information not submitted.

• 53: Surgical Outcomes of SWOG1801: Neoadjuvant/adjuvant versus adjuvant pembrolizumab for resectable stage III-IV melanoma

  Friday, March 24, 2023
  1:25 PM – 1:37 PM

  Disclosure information not submitted.